Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-27 | "Mr. Riccitelli currently serves as Chairman... From 2012 to 2017, Mr. Riccitelli served as President and Chief Executive Officer... of Signal Genetics... [and] Executive Vice President and Chief Operating Officer of Genoptix..." |
| 2019-04-15 | "Mr. Riccitelli currently serves as Chairman... From 2012 to 2017, Mr. Riccitelli served as President and Chief Executive Officer... of Signal Genetics..." |
| 2020-04-17 | "Mr. Riccitelli... served as Chief Executive Officer of Pathnostics, a diagnostics company..." |
| 2021-04-16 | "Mr. Riccitelli... has served as Chief Executive Officer of Pathnostics... and... President and Chief Executive Officer and a Director of Signal Genetics, Inc." |
| 2022-04-15 | "Mr. Riccitelli’s extensive experience with healthcare companies, particularly emerging companies, qualifies him to serve on our board of directors." |
| 2023-04-28 | "Mr. Riccitelli has served as a board director for Biocept... From 2019 to 2020 he served as Chief Executive Officer of Pathnostics..." |
| 2024-04-08 | "Mr. Riccitelli served as... Chairman of the Board... interim President and Chief Executive Officer... extensive experience with healthcare companies." |
| 2025-04-02 | "We believe Mr. Riccitelli’s extensive experience with healthcare companies, particularly emerging companies, qualifies him to serve on our board of directors." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04